Rheumatic heart prevention program for Ugandan communities
Part of Heart & circulation, Infections clinical trials.
This study helps deliver prevention care for rheumatic heart disease in specific districts of northern Uganda. If you live there (or provide care in the selected clinics), the program may offer extra support to help stop heart damage before it starts.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You live in one of the two study districts in Uganda
- OR you work as a health provider at a specific clinic level (HCIII or HCIV)
- Your clinic is located in one of the two study districts
- There are no listed exclusion criteria
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new strategy to help people in Uganda who were found to have rheumatic heart disease (a condition affecting the heart valve) stay connected to their care. Researchers want to understand what works best to keep patients from being lost to follow-up and ensure they get the treatment they need.
This study looks at whether building a better, sustainable cardiac surgery service can reduce the burden of rheumatic heart disease. It focuses on patients who need cardiac surgery at a specific hospital during a training and research program.
This study tests whether a fun, educational program (with games and activities) can help students in Nepal learn more about rheumatic fever and rheumatic heart disease. If you are in grades 6–9 at a public school, you may be able to join and help see if this approach works.
This study tests whether a prevention program done at a specific school can reduce how common “latent” (hidden) rheumatic heart disease is in children. If you attend the study’s school in Tulsipur, this program may be offered to help protect students’ heart health over time.
This study is looking for people living in rural areas of Sindh, Pakistan, to help screen for and prevent rheumatic heart disease. It aims to find and treat the condition early.
This study is testing whether a vaccine can prevent rheumatic heart disease in children. It involves children aged 5 to 8 years who are healthy, live in certain areas, and have no history of heart problems. The study will check children's hearts with an ultrasound and follow them over time.
Hear when a new Rheumatic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.